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Introduction
The circadian clock controls many rhythmic physiological processes such as hormonal oscillation, metabolism and immune function that are essential to maintain homeostasis [1, 2] . At the molecular level, the circadian clock establishes these biological rhythms through interconnected transcription-translation feedback loops (TTFLs). The core loop is composed of BMAL, CLOCK, Period (PER1, PER2) and Cryptochrome (CRY1, CRY2).
BMAL-CLOCK heterodimers transcriptionally activate the expression of PER and CRY and other circadian output genes. In turn, PER and CRY suppress their own expression and expression of other circadian output genes controlled by the BMAL-CLOCK complex [3, 4] . PER2 suppresses BMAL/CLOCK mediated transcription by displacing BMAL/CLOCK/CRY complexes from target promoters. This displacement is not only important for inhibition of circadian gene expression, but also essential for reactivation of the TTFL [5] . This core loop regulates expression of retinoic acid receptor-related orphan receptor (ROR) and REV-ERBα/β (NR1D1, NR1D2) which form a secondary loop that stabilizes the core loop by regulating BMAL1 and CRY1 transcription [6] [7] [8] .
The robustness and stability of circadian rhythm is also reinforced by post-translational modifications (PTMs) that determine the level, activity and subcellular localization of core clock proteins [9] [10] [11] [12] [13] [14] . For example, phospho-null mutation at PER2 Serine 662 enhances PER2 repressor function but increases PER2 turnover in the nucleus. Loss of PER2 S662 phosphorylation (typically the result of a PER2 S662G substitution) causes human Familial Advanced Sleep Phase Syndrome (FASPS) which is characterized by a dramatically shortened circadian period with a 4-hour advance of sleep, temperature, and melatonin rhythms [15, 16] . Besides phosphorylation and ubiquitination, the core clock proteins are also subject to other PTMs such as small ubiquitin-related modifier (SUMO)ylation, acetylation and O-linked β-N-acetylglucosamine modification [12] .
In addition to its circadian role, PER2 exhibits tumor suppressive functions in many cancers [17] [18] [19] . Suppression of PER2 at both gene expression and protein levels facilitates tumor growth, invasion and cancer malignancy [19] [20] [21] [22] . Since PER2 protein level oscillates and PER2 shuttles between nucleus and cytoplasm, PTMs that affect PER2 stability and subcellular localization can determine both its circadian transcriptional suppression activity and tumor suppressor activity.
Among the known PER2 PTMs, phosphorylation has been most intensively studied [13] . Two important serine phosphorylation sites (S662, S480) have been identified. Phosphorylation at S662
(the FASP site) affects PER2 subcellular localization and therefore influences transcription of PER2 itself and its downstream genes [16, 23] . Phosphorylation at S480 facilitates PER2-β-TrCP interaction leading to PER2 proteasomal degradation (β-TrCP phosphodegron) [24] . Recent research has suggested that casein kinase 1 (CK1) is responsible for PER2 phosphorylation at both S662 and S480 [25] ; however, the factors that determine which site will be phosphorylated remain unknown.
Other PTMs also can regulate PER2 protein stability and subcellular localization. For example, O-GlcNAcylation in a cluster of serines around S662 competes with phosphorylation to regulate PER2 repressor activity [26] . Acetylation of PER2 at lysine (K) residues protects PER2 from ubiquitination; whereas deacetylation of PER2 by SIRT1 leads to degradation [27] . Despite these investigations of PER2 PTMs, little is known about PER2 SUMOylation.
The effects of SUMOylation on protein function are multifaceted. SUMOylation can alter protein-protein interactions, protein subcellular localization or protein activity and can participate in transcriptional regulation [28, 29] . Usually, SUMO modification does not promote protein degradation. However, for a subset of proteins, conjugation with multiple SUMOs is critical for recognition by SUMO-targeted ubiquitin ligases (STUbLs), leading to proteasomal degradation [30] .
At least three major SUMO proteins in higher eukaryotes have been identified: SUMO1 and SUMO2/3. SUMO2 and SUMO3 are 97% identical, but they share less than 50% sequence identity with SUMO1. SUMO2/3 often form SUMO chains on the substrates, whereas SUMO1 typically appears as monomers or acts as a chain terminator on SUMO-2/3 polymers [31] . However, SUMO1 
Results and Discussion

PER2 can be SUMOylated
Analysis of endogenous PER2, SUMO1 and SUMO2 levels in HEK-293T cells at different circadian times (CT) after serum shock showed that PER2 had a rhythmic oscillation from high protein abundance at CT1 and CT5 to lower protein levels from CT13 to CT21 (Fig EV1A, Top) while SUMO1 and SUMO2 did not show significant rhythmic changes ( Fig EV1A) Immunoprecipitation (IP) confirmed that PER2 was SUMO-conjugated ( Fig 1B) . PER2-SUMOylation was further confirmed by detection of SUMO-conjugated PER2 in HEK-293T cells ectopically expressing tagged-PER2 and SUMO1 or SUMO2 ( Fig 1C, lane 3 and 6 ). Importantly, co-expression of SUMO1 or SUMO2 with SENP1, a SUMO protease, eliminated the PER2 band shift ( Fig 1C, lane 4 and 7) , confirming that PER2 could be SUMOylated by both SUMO1 and SUMO2.
SUMO2 promotes PER2 protein degradation
Interestingly, the signal of PER2-SUMO2 modification was less prominent than that of PER2-SUMO1 ( Fig 1C, lane 6 vs. lane 3), suggesting that SUMO2 modification may lead to PER2 ubiquitination and proteasomal degradation. Consistent with this hypothesis, treatment with the proteasome inhibitor MG132 resulted in accumulation of PER2-SUMO2 conjugates ( Fig 1D, lane 12 vs. lane 9). Also, PER2 protein levels decreased in a dose-dependent manner upon SUMO2 expression ( Fig 2A) . Immunoblot (IB) assay using whole cell lysates from cycloheximide (CHX)treated cells further showed that SUMO2, but not SUMO1, significantly shortened PER2 protein halflife ( Fig EV1B) . To demonstrate that SUMO2-conjugation promoted PER2 degradation via ubiquitination, Co-IP assay was performed using HEK-293T cells ectopically expressing FLAG- In contrast, SUMO1 did not affect PER2 protein stability (Fig 2A) .
Lysine 736 is important for PER2 SUMOylation and required to maintain correct circadian period
The majority of known SUMO substrates are SUMOylated at a lysine in the consensus motif ψKxD/E (where ψ is a large hydrophobic residue) [40] . However, SUMOylation can also occur at lysine residues outside this motif. Two putative PER2 SUMOylation sites at K87 and K1163 were identified using the GPS-SUMO bioinformatics database [41] ( Fig 2B) .
An additional
SUMOylation motif, QKEE [42], was also identified at K736 by manual inspection of the PER2 sequence. PER2 K736 and K1163 are conserved between human and mouse ( Fig S1) .
To determine which of these putative PER2 SUMOylation sites are functionally important, a series of K to Arginine (R) PER2 mutations at K87, K736 and/or K1163 were created. The K736R mutation clearly inhibited SUMO2-mediated PER2 degradation while K87R and K1163R had no effect ( Fig EV2A) . We further tested PER2 double and triple mutants and found that whenever K736 was mutated, PER2 protein became more stable regardless of whether K87 or K1163 could be SUMOylated ( Fig EV2B) . These data indicated that K736 could be an important SUMOylated site of PER2. Consistent with this, liquid chromatography-tandem mass spectrometry (LC-MS/MS) using lysates prepared from HEK-293T cells transiently expressing FLAG-PER2 and EGFP-SUMO1
identified a SUMO peptide branch at K736 of PER2 ( Fig 2C) . In addition, denatured-IP assays confirmed that the PER2 K736R mutation significantly decreased both SUMO1 and SUMO2 conjugation ( Fig 2D, 2E ). While the mass spectrometry data demonstrated that K736 is itself SUMOylated, we do not rule out the possibility that mutation of K736 also affects SUMOylation at other unidentified sites. Also consistent with the critical importance of PER2 K736, co-IP showed a significant decrease in PER2 K736R interaction with β-TrCP ( Fig 2F) . β-TrCP-containing Skp-Cullin-F-box (SCF) complexes have been shown to mediate PER2 degradation in response to S480 phosphorylation [24, 43] . Together these results demonstrated that PER2 K736 is critical for PER2 SUMOylation.
PER2 K736 was also critical for maintenance of correct circadian period. Stable clones of HEK-293T cells harboring the PER2 K736R mutation were generated by CRISPR/CAS editing ( Fig   EV3) . Analysis of circadian rhythm using a PER2 luciferase reporter showed that the PER2 K736R cells had lower circadian peak amplitude and their peak time was shifted forward by about 3 circadian hours compared to PER2 WT cells ( Fig 2G, 2H) . These observations demonstrated that PER2 K736, and K736-dependent SUMOylation, were required for proper circadian regulation.
PER2 K736-dependent SUMO1 conjugation is a signal for CK1-mediated phosphorylation and accumulation in the nucleus.
In contrast to the effect of SUMO2 to destabilized PER2, subcellular fractionation showed that SUMO1 expression promoted PER2 cytoplasm-to-nuclear translocation and chromatin association ( Fig 3A) . This differed from observations in SUMO2-expressing cells where the majority of PER2 that was not degraded remained in the cytoplasm ( Fig 3A) . We therefore sought to determine the mechanisms of PER2 SUMO1 conjugation and how it influenced PER2 nuclear translocation.
Phosphorylation can affect PER2 localization [16, 23] .
Rhythmic changes in PER2
phosphorylation are controlled by coordination between casein kinase (CK1) and phosphoprotein phosphatase 1 (PPP1) and are crucial for modulating circadian rhythm [24, [44] [45] [46] [47] . Two functional CK1 targeted phosphorylation sites in human PER2, S480 (S478 in mPer2) and S662 (S659 in mPer2), have been identified [23, 24] . Comparing our data with previous results, it was intriguing to note that PER2 K736-mediated SUMO1-conjuation and S662 phosphorylation both led to increased PER2 nuclear retention ( Fig 3A) [23] . Conversely, K736-mediated SUMO2-conjugation and S480 phosphorylation both promoted PER2 ubiquitination and proteasomal degradation (Fig 2A, EV1B , EV1C) [24, 43] . To determine whether there is a relationship between PER2 SUMO1 versus SUMO2 conjugation and PER2 phosphorylation, we first used the CK1δ/ε inhibitor PF670462 to determine whether loss of phosphorylation prevents PER2 SUMOylation ( Fig 3B) . This analysis found that inhibition of CK1 reduced PER2 S662 phosphorylation but did not affect PER2 SUMOylation ( Fig 3B) . However, PER2 K736R had reduced S662-phosphorylation and slightly decreased CK1 interaction ( Fig 3C) . PER2 K736R also led to a decrease in soluble nuclear and chromatin-bound protein compared to PER2 WT ( Fig 3D) . Taken together, these data indicate that K736-mediated SUMO1 conjugation may serve as a critical signal upstream of CK1 to promote CK1 phosphorylation of S662 and thereby promote PER2 nuclear entry.
PER2 SUMO1 conjugation mediated by RanBP2 promotes CK1 phosphorylation of PER2 S662 and CRY1/GAPVD1 interactions required for PER2 nuclear translocation.
Unlike ubiquitination, E3 ligases are not required for protein SUMOylation as the SUMO E2conjugating enzyme UBC9 is able to conjugate SUMO onto target proteins [48, 49] . In the case of PER2, however, both SUMO1 and SUMO2 can be conjugated on the same K736 site. Therefore, a specific SUMO E3-ligating enzyme may be required for specific SUMO isoform conjugation to determine PER2 protein fate. As SUMO1 conjugation promoted PER2 nuclear entry, we hypothesized that the nucleoporin RanBP2, an E3 enzyme known to mediate SUMO1 conjugation to target proteins for nuclear import [28, 50] , could be responsible for PER2-SUMO1 conjugation. In addition, CK1-PER2 interaction and PER2 S662phosphorylation were also significantly decreased upon RanBP2 depletion ( Fig 4D) . Together, these results suggest that RanBP2-mediated PER2-SUMO1 conjugation is critical for CK1-mediated PER2 phosphorylation at S662 to promote PER2 nuclear entry.
Consistent with this hypothesis, depletion of RanBP2 in HEK-293T cells (Fig
PER2 nuclear entry is facilitated by dimerization with CRY1 [23,51-53] and interaction of the PER2/CRY/CKI complex with GAPVD1, a Rab GTPase guanine nucleotide exchange factor involved in endocytosis and cytoplasmic trafficking [54]. Consistent with these previous observations, PER2 K736R had significantly decreased CRY1 and GAPVD1 interaction ( Fig 4E, 4F ).
Taken together, these results indicate that PER2 SUMOylation by SUMO1 is an important signal to promote the subsequent S662 phosphorylation and protein interactions that needed for PER2 translocation into the nucleus.
SUMOylation is critical for PER2 mediated transcriptional suppression.
As a key player in the core circadian TTFL, changes in PER2 subcellular localization and protein stability will affect the expression of circadian-regulated genes, particularly those in auxiliary feedback loops such as nuclear receptors REV-ERBs and RORs [6, 55] . Therefore, we examined the expression of REV-ERBα, REV-ERBβ, RORα and RORγ in HEK-293T cells overexpressing PER2 WT or PER2 K736R . REV-ERBα, REV-ERBβ and RORγ, but not RORα, were repressed upon PER2 WT expression. In contrast, PER2 K736R caused all of these genes to be expressed at higher level than both control cells and PER2 WT expressing cells ( Fig 4G) . This confirmed that K736 modification was essential for PER2 transcriptional repression and was consistent with SUMO1mediated PER2 nuclear entry (Fig 3) . In the core TTFL, PER2 dimerizes with CRY1 to suppress its own expression. Consistent with this, and with our findings that SUMO1 enhanced PER2-CRY1
interaction, transient reporter assays demonstrated that co-expression of PER2 WT with SUMO1
repressed PER2 promoter activity ( Fig 4H) . Further repression was observed when a higher level of SUMO1 was expressed ( Fig 4H) . In line with the observation of SUMO1-mediated PER2 nuclear translocation (Fig 3) , these further indicate that PER2 modification by SUMO1 is critical for its transcriptional suppressor function in regulating circadian genes.
Recent evidence indicates that many SUMO targets can be modified by both SUMO1 and SUMO2/3 [56] . However, the mechanisms balancing SUMO1 versus SUMO2/3 conjugation are still not clear. One possibility is that differential regulation is primarily due to the relative expression level of SUMO isoforms [38] . Another possibility is that SUMO1 and SUMO2/3 may have different conjugation site preferences [56, 57] . In the case of PER2, K736 is important for both SUMO1 and SUMO2 conjugation ( Fig 2D, 2E ). PER2 SUMO1 modification is strongly promoted by RanBP2 (Fig 4) and important for CK1-mediated PER2 phosphorylation at S662. In contrast, PER2 S480 phosphorylation and SUMO2 modification both promote PER2 degradation. However, S480 is more distal to K736 than S662 and it is not known how SUMO2 conjugation at K736 may affect S480 phosphorylation (or vice versa). The SUMO E3 ligase responsible for PER2-SUMO2 conjugation also remains unknown and its identification will be of interest for future research.
In summary, our experiments identified SUMOylation as a key post-translational modification governing PER2 protein stability, transcriptional suppressor function ( Fig 5) and maintenance of circadian regulation. PER2 K736 was found to be critical for SUMOylation by multiple SUMO isomers. RanBP2-mediated SUMO1 conjugation promotes PER2 phosphorylation, cytosol-tonuclear translocation and thereby enhances its transcriptional repression activity. Conversely, PER2
K736-mediated SUMO2 conjugation is essential to facilitate PER2 protein interaction with β-TrCP and its subsequent turnover via ubiquitination-mediated degradation. Thus, SUMO1 versus SUMO2 conjugation forms a critical crossroads controlling the PER2 fate and influences PER2 activities in circadian regulation and tumor suppression. Discovery of this crossroads determining PER2 function provides new insights into the regulation of PER2 specifically as well as the function of SUMOylation in circadian regulation more broadly.
Materials and Methods
Cell line Immortalized human embryonic kidney cell HEK-293T and phenotypically normal breast epithelial cell MCF-10A were cultured using the standard growth medium according ATCC in a humidified 37 °C incubator supplemented with 5% CO2. Serum shock was performed with DMEM supplemented with 50% horse serum (GIBCO) for 2 h when cells reached ~80% confluence. The medium was then replaced with DMEM supplemented with 0.1% FBS. At the time indicated, the cells were washed twice with ice-cold PBS and whole-cell lysates prepared using RIPA lysis buffer (50 mM Tris-HCl (pH7.4), 150 mM NaCl, 1% NP40, 0.25% sodium deoxycholate, 0.05% SDS, 1 mM PMSF, 1x protease inhibitor, with or without 10 mM NEM). Appendix Table S2 .
Generation of PER2 K736R knock-in mutant
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was used as an internal control for mRNA expression. Expression levels were calculated according to the relative ΔCt method.
Co-immunoprecipitation (Co-IP)
Whole-cell lysates were prepared using a TNE lysis buffer (10 mM Tris-Cl (pH 7.5), 150 mM NaCl, 0.5 mM EDTA, 1% NP-40, 10 µM MG132, 1 mM PMSF, 10 mM NEM and 1x protease inhibitors) followed by sonication and centrifugation at 12,000 × g at 4°C.
1 ml of the crude whole-cell extract was incubated with 1-2 μg of antibody as indicated or control IgG antibodies at 4°C overnight. Then, 50 μl prewashed protein A/G agarose was added to the mixture and incubated at 4°C for 4 h with gentle agitation. After extensive washing with diluted NP-40 lysis buffer (0.1-0.5% NP-40), PER2 interacting proteins were eluted with SDS buffer and analyzed by immunoblot. Antibodies and agarose used for PER2 IP were listed in Appendix Table   S3 . Data are means ± SD, n=3 (H).
Denatured-IP
All experiments were performed at least twice with similar results. 
